210 related articles for article (PubMed ID: 24436122)
1. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance.
Auger M
Cancer Cytopathol; 2014 Apr; 122(4):241-9. PubMed ID: 24436122
[TBL] [Abstract][Full Text] [Related]
2. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
4. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
5. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
8. Subclassification of "atypia of undetermined significance" in thyroid fine-needle aspirates.
Wu HH; Inman A; Cramer HM
Diagn Cytopathol; 2014 Jan; 42(1):23-9. PubMed ID: 24166935
[TBL] [Abstract][Full Text] [Related]
9. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle cytology of Hürthle cell tumors and morphometry.
Zeppa P; Vitale M
Cancer Cytopathol; 2014 Jul; 122(7):553. PubMed ID: 24706512
[No Abstract] [Full Text] [Related]
11. Reply to fine-needle cytology of Hürthle cell tumors and morphometry.
Auger M
Cancer Cytopathol; 2014 Jul; 122(7):553-4. PubMed ID: 24706500
[No Abstract] [Full Text] [Related]
12. An Insight into the Utility of Sub-Categorisation of Atypia of Undetermined Significance for Risk Stratification: A Retrospective Study on an Indian Cohort with Histopathological Correlation.
Roy S; Prabhu AJ; Abraham DT; Mazhuvanchary Jacob P; Manipadam MT
Acta Cytol; 2019; 63(3):182-188. PubMed ID: 30889578
[TBL] [Abstract][Full Text] [Related]
13. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
14. Young investigator challenge: Atypia of undetermined significance in thyroid FNA: Standardized terminology without standardized management--a closer look at repeat FNA and quality measures.
Brandler TC; Aziz MS; Coutsouvelis C; Rosen L; Rafael OC; Souza F; Jelloul FZ; Klein MA
Cancer Cytopathol; 2016 Jan; 124(1):37-43. PubMed ID: 26765064
[TBL] [Abstract][Full Text] [Related]
15. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy.
Renshaw AA
Cancer Cytopathol; 2011 Oct; 119(5):322-7. PubMed ID: 21442771
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, hurthle cell type" in patients with hashimoto thyroiditis.
Roh MH; Jo VY; Stelow EB; Faquin WC; Zou KH; Alexander EK; Larsen PR; Marqusee E; Benson CB; Frates MC; Gawande A; Moore FD; Cibas ES
Am J Clin Pathol; 2011 Jan; 135(1):139-45. PubMed ID: 21173136
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
Alaedeen DI; Khiyami A; McHenry CR
Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hürthle cell lesions by fine-needle aspiration.
Yang YJ; Khurana KK
Arch Pathol Lab Med; 2001 Aug; 125(8):1031-5. PubMed ID: 11473452
[TBL] [Abstract][Full Text] [Related]
19. The role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience.
Rossi ED; Straccia P; Martini M; Revelli L; Lombardi CP; Pontecorvi A; Fadda G
Cancer Cytopathol; 2014 May; 122(5):359-67. PubMed ID: 24474727
[TBL] [Abstract][Full Text] [Related]
20. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
Montone KT; Baloch ZW; LiVolsi VA
Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
